LIMD1+/+ tumours were unaffected by PF-477736 treatment in vivo, however we observed a significant decrease in tumour growth in the LIMD1−/− tumours upon treatment (Figs. 4E and S4A, B). Here, LIMD1 is linked to neoplasm.